https://www.selleckchem.com/pr....oducts/wnt-agonist-1
In-hospital (12.2% vs 4.7%, p  0.0001) and 30-day (16.3% vs 8.9%, p = 0.0001) mortality was higher in patients with CV events, as well as the re-hospitalisation rate (13.3% vs 9.3%, p = 0.002), and mean hospital stay was 11.4 ± 6.9 vs 9.5 ± 5.6 days (p  0.0001). The occurrence of CV events during hospitalisation significantly increased the risk of 30-day mortality (HR 1.69, 95% CI 1.14-2.51; p = 0.009). Cardiovascular events are frequent in CAP, and their occurrence adversely affects outcome. A strict monitoring might be u